About 1 100 reports

  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL DURATION BY
  • shows that, when gastrointestinal clinical trials are segmented by molecular target,

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Clinical Trial
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
  • GLOBAL - GASTROINTESTINAL CANCER LIQUID BIOPSY MARKET (MILLION US$), 2015 - 2017

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Biopsy
  • Clinical Trial
  • World
  • Forecast
  • Market Size
  • VOLTAGE-BASED CONTRAST MEDIA ADAPTATION IN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (VOLCANIC-CTA)
  • CARDIOVASCULAR DISORDERS TO DOMINATE CONTRAST MEDIA/CONTRAST

MRI contrast agents are used in the detection of various abnormalities like gastrointestinal, intravascular, hepatobiliary, and reticuloendothelial disorders.

  • Biopsy
  • Ultrasound
  • North America
  • United States
  • GE Healthcare Limited

ipage=##& xml=##& quest=##& rid=##& section=##& sequence=-##& pdf=##& dn=## [Accessed February ##, 2017].

  • Biopsy
  • Clinical Trial
  • Ultrasound
  • Pfizer Inc.
  • Roche Group

REST OF WORLD PART D: ANNEXURE ##.

  • Biopsy
  • Clinical Trial
  • Ultrasound
  • United States
  • Market Shares

Gastrointestinal Cancer ##. ##. ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GLOBAL LIQUID BIOPSY MARKET FORECAST 2018-2026 ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Clinical Trial
  • Diagnostics
  • Ultrasound
  • World

GLP-## agonists have been associated with a common side effect of gastrointestinal disturbances such as nausea and vomiting, which can reduce patient compliance (Prasad-Reddy and Isaacs, 2015).

  • Clinical Trial
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • SEGMENTATION OF GLOBAL PORTABLE ULTRASOUND EQUIPMENT MARKET BY APPLICATION 2016
  • SEGMENTATION OF GLOBAL PORTABLE ULTRASOUND EQUIPMENT MARKET BY APPLICATION

About Portable Ultrasound Portable ultrasound devices are imaging devices that utilize echo-enhanced ultrasound waves to aid in medical diagnosis. They are convenient to carry since they are lighter and smaller than conventional ultrasound machines. Portable ultrasound devices can be used at POC and operated on battery power....

  • Healthcare
  • Ultrasound
  • World
  • Forecast
  • GE Healthcare Limited
  • 6.3 LIQUID BIOPSY MARKET: COMPETITIVE TECHNOLOGY PORTFOLIO

(UK) COMPANY ## COMPANY ## Trovagene, Inc.

  • Biopsy
  • Clinical Trial
  • Ultrasound
  • United States
  • Market Size
  • OPPORTUNITIES

TABLE ##.

  • Clinical Trial
  • World
  • Forecast
  • Market Size
  • Charles River Laboratories International, Inc.
  • 8.5.2 Product Portfolio
  • 9. Global Biopsy Device Market - Mergers and Acquisitions/Key Deals

Intended for one-time use. ##.

  • Biopsy
  • Ultrasound
  • World
  • Forecast
  • Boston Scientific Corporation

Phase ## and Phase ##, then phase ## WHICH ONE IS THE FASTEST GROWING?

  • Clinical Trial
  • Pharmaceutical
  • Forecast
  • Market Size
  • Supply

Phase ## and Phase ##, then phase ## WHICH ONE IS THE FASTEST GROWING?

  • Clinical Trial
  • World
  • Forecast
  • Market Size
  • Supply

Additionally, as CF is a multi-system disease pancreatic, gastrointestinal and reproductive problems will remain even if the lung transplant is successful.

  • Biopsy
  • Clinical Trial
  • World
  • Market Size
  • Alexion Pharmaceuticals, Inc.

Gastrointestinal and Gliomas are the other important type of cancer.

  • Biopsy
  • Clinical Trial
  • Heart Transplant
  • Ultrasound
  • World

Some of the prominent trends that the market is witnessing include rising geriatric population and high prevalence of gastrointestinal tract-related cancers.

  • Biopsy
  • Ultrasound
  • APAC
  • World
  • Forecast

Grade ## hypertension (##% vs ##%), proteinuria (##% vs ##%), arterial thromboembolic events (##% vs ##%), and gastrointestinal perforation (##% vs ##%) were more commonly observed in the bevacizumab plus mIFL group than in the mIFL group.

  • Biopsy
  • Cancer
  • Clinical Trial
  • World
  • Merck & Co., Inc.

All treatment regimens were well tolerated, with a similar incidence of upper gastrointestinal (GI) AEs.

  • Biopsy
  • Clinical Trial
  • Therapy
  • Ultrasound
  • Amgen Inc.

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using Metolate.

  • Biopsy
  • Clinical Trial
  • World
  • AbbVie Inc.
  • Allergan plc

Other symptoms include retrosternal pain, weight loss, hematemesis (vomiting blood) and melena (black feces associated with gastrointestinal hemorrhage).

  • Biopsy
  • Clinical Trial
  • Ultrasound
  • World
  • AbbVie Inc.

Biologics are susceptible to metabolism in the gastrointestinal tract and lack permeability, which collectively leads to poor bioavailability.

  • Clinical Trial
  • Ultrasound
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.

Gastrointestinal Cancer Research; ##(##): ##-## Mayo Clinic (2014).

  • Clinical Trial
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Clinical Trial
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

The ACURATE family of valve products is one of two valve systems in the Boston Scientific structural heart portfolio.

  • Clinical Trial
  • Prosthesis
  • United States
  • Edwards Lifesciences Corporation
  • Valtech Cardio, Ltd.

As such, non-selective COX inhibitors typically produce COX-## inhibitory gastrointestinal (GI) side effects, including gastric ulceration, bleeding and perforation.

  • Clinical Trial
  • World
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • Clinical Trials by E7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials
  • Clinical Trials by G7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015" provides data on the Functional (Non Ulcer) Dyspepsia clinical trial scenario. This report provides elemental information and data...

  • Biopsy
  • Clinical Trial
  • World
  • Astellas Pharma Inc.
  • Zeria Pharmaceutical Co., Ltd.

ONE UNIT REFERS TO ONE PAC.

  • Ultrasound
  • Market Size
  • Asahi Kasei Corporation
  • Boston Scientific Corporation
  • Cardinal Health, Inc.

Heparin is given intravenously due to poor gastrointestinal tract absorbability.

  • Clinical Trial
  • Heart Transplant
  • Ultrasound
  • World
  • Merck & Co., Inc.